Erythrocytes and the Transport of Drugs and Endogenous Compounds

Pharmaceutical Research

Volumn 13, Issue 2, 1996, Pages 186-195

  Highley, Martin S ^a   De Bruijn, Ernst A ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Biological transport; Blood specimen collection; Erythrocytes; Hydrocortisone; Phenytoin; Plasma; Protein binding; Valproic acid

Indexed keywords

HYDROCORTISONE; PHENYTOIN; VALPROIC ACID; PLASMA PROTEIN; WATER;

DRUG PROTEIN BINDING; DRUG TRANSPORT; ERYTHROCYTE; HEMATOCRIT; HUMAN; MEASUREMENT; PARTITION COEFFICIENT; PRIORITY JOURNAL; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; ANIMAL; BLOOD; METABOLISM;

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; ERYTHROCYTES; HUMANS; HYDROCORTISONE; PHENYTOIN; VALPROIC ACID; WATER;

EID: 0029658249     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016074627293     Document Type: Review

References (50)

1. M. Ehrnebo. Drug binding to erythrocytes. In J. P. Tillement and E. Lindenlaub (eds.). Protein binding and drug transport, Symposia Medica Hoechst 20. F K Schattauer Verlag, Stuttgart-New York, ISBN 3-7945-1123-9, 1986, pp. 49-57. Discussion pp 59-61.
2. O. Driessen, L. Treuren, and J. W. A. Meijer. Distribution of drugs over whole blood: I The transport function of whole blood for valproate. Ther. Drug Monit. 11:384-389 (1989).
3. O. Driessen, L. Treuren, J. W. A. Meijer, and J. Hermans. Distribution of drugs over whole blood: II The transport function of whole blood for phenytoin. Ther. Drug Monit. 11:390-400 (1989).
4. O. Driessen, L. Treuren, A. J. Moolenaar, and J. W. A. Meijer. Distribution of drugs over whole blood: III The transport function of whole blood for hydrocortisone. Ther. Drug Monit. 11:401-407 (1989).
5. O. Driessen, L. Treuren, A Moolenaar, J.W.A. Meijer, and P. Verheijen. In vivo distribution of hydrocortisone over whole blood: A novel method for the extraction of erythrocytes. Meth. Find. Exp. Clin. Pharmacol. 12:119-126 (1990).
6. T. C. Pearson and D. L. Guthrie. Trapped plasma in the microhematocrit. Am. J. Clin. Pathol. 78:770-772 (1982).
7. D. Kurata and G. R. Wilkinson. Erythrocyte uptake and plasma binding of diphenylhydantoin. Clin. Pharmacol. Therap. 16:355-362 (1974).
8. W. A. Colburn and M. Gibaldi. Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate. Drug. Metab. Dispos. 6:452-455 (1978).
9. C. Hariton, G. Jadot, M. Valli, E. Mesdjian, and P. Mandel. Effects of sodium valproate on diazepam: kinetic profiles in plasma, erythrocytes, and different brain areas in the rat. Epilepsia 26:74-80 (1985).
10. H. Mabuchi and H. Nakahashi. A major inhibitor of phenytoin binding to serum protein in uremia. Nephron 48:310-314 (1988).
11. J. W. A. Meijer. Knowledge, attitude and practice in antiepileptic drug monitoring. A. Neur. Scand. 83:Suppl 134,100-104 (1991).
12. P. Borondy, W. A. Dill, T. Chang, R. A. Buchanan, and A. J. Glazko. Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells. Ann. N. Y. Academ. Sci. 226:82-87 (1973).
13. R. J. Shirkey, L. B. Jellett, D. C. Kappatos, T. J. B. Maling, and A. Macdonald. Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease. Eur. J. Clin. Pharmacol. 28:447-452 (1985).
14. R. Hiramatsu and B. C. Nisula. Erythrocyte-associated component of blood cortisol. Ann. N. Y. Acad. Sci. 538:159-166 (1988).
15. M. Ehrnebo, S. Agurell, L. O. Boréus, E. Gordon, and U. Lönroth. Pentazocine binding to blood cells and plasma proteins. Clin. Pharmacol. Ther. 16:424-429 (1974).
16. J. I. Javaid, J. M. Davis, and M. Maiorano. Uptake and/or binding of tricyclic antidepressants in human red cells. Life Sciences 36:1761-1769 (1985).
17. N. M. Graves, G. B. Holmes, I. E. Leppik, T. K. Galligher, and D. R. Parker. Quantitative determination of phenytoin and phenobarbital in capillary blood by Ames seralyzer. Epilepsia 28:713-716 (1987).
18. O. Driessen, R. J. Höppener, and E. A. van der Velde. Practical and theoretical aspects of phenytoin administration. Eur. Neurol. 19:353-365 (1980).
19. K. Nagasawa, N. Kitada, C. Tsuji, M. Ogawa, T. Yokoyama, N. Ohnishi, S. Iwakawa, and K. Okumura. Distribution of pirarubicin in human blood. Chem. Pharm. Bull. 40:2866-2869 (1992).
20. T. Ito, T. Yamaguchi, H. Miyazaki, Y. Sekine, M. Shimizu, S. Ishida, K. Yagi, N. Kakegawa, M Seino, and T. Wada. Pharmacokinetic studies of AD-810, a new antiepileptic compound. Arzneim. Forsch/Drug Res. 32:1581-1586 (1982).
21. V. P. Shah, M. A. Walker, J. P. Hunt, D. Schuirmann, V. K. Prasad, and B. E. Cabana. Thiazides XI: partitioning of chlorothiazide in red blood cells after oral administration. Biopharm. Drug Dis. 6:55-62 (1984).
22. E. H. Starling. On the absorption of fluids from the connective tissue spaces. J. Physiol. 19:312-326 (1895).
23. B. Legg, S. K. Gupta, M. Rowland, R. W. G. Johnson, and L. R. Solomon. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration. Eur. J. Clin. Pharmacol. 34:451-460 (1988).
24. W. M. Pardridge and E. M. Landaw. Testosterone transport in brain: primary role of plasma protein-bound hormone. Am. J. Physiol. 249:E534-E542 (1985).
25. C. M. Mendel, R. R. Cavalieri, and R. A. Weisiger. Letter to the editor: on plasma protein-mediated transport of steroid and thyroid hormones. Reply by W. M. Pardridge. Am. J. Physiol. 255:E221-E227 (1988).
26. E. M. Cornford and K. P. Landon. Blood-brain barrier transport of CI-912: Single passage equilibration of erythrocyte-borne drug. Ther. Drug Monit. 7:247-254 (1985).
27. D. L. Kooyman, G. W. Byrne, S. McClellan, D. Nielsen, M. Tone, H. Waldmann, T. M. Coffman, K. R. McCurry, J. L. Platt, and J. S. Logan. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89-92 (1995).
28. W. H. Reinhart. Binding of cyclosporine by erythrocytes: influence on cell shape and deformability. Eur. J. Clin. Invest. 23:177-81 (1993).
29. F. O. Ajayi, L. A. Salako, and J. O. Kuye. Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria. Afr. J. Med. med. Sci. 18:95-100 (1989).
30. P. J. Marroum and S. H. Curry. Red blood cell partitioning, protein binding and lipophilicity of six phenothiazines. J. Pharm. Pharmacol. 45:39-12 (1993).
31. M. Razavi, M. Kraupp, and R. Marz. Allopurinol transport in human erythrocytes. Biochem. Pharmacol. 45:893-897 (1993).
32. C. A. Goresky, G. G. Bach, and B. E. Nadeau. Red cell carriage of label. Its limiting effect on the exchange of materials in the liver. Circ. Res. 36:328-334 (1975).
33. C. G. Caro, T. J. Pedley, R. C. Schroter, W. A. Seed (eds.). The systemic microcirculation. In The mechanics of the circulation. Oxford Univ Press, ISBN 0-19-261171-2, 1978, pp. 350-429.
34. C. A. Goresky, A. J. Schwab, and C. P. Rose. Xenon handling in the liver: red cell capacity effect. Circul. Res. 63:767-778 (1988).
35. A. Tajima, H. Nakata, S-Z. Lin, V. Acuff, and J. Fenstermacher. Differences and similarities in albumin and red blood cell flows through cerebral microvessels. Am. J. Physiol. 262:H1515-1524 (1992).
36. W. C. Darbonne, G. C. Rice, M. A. Mohler, T. Apple, C. A. Hébert, A. J. Valente, and J. B. Baker. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J. Clin. Invest. 88:1362-1369 (1991).
37. R. Kravtzoff, C. Ropars, M. Laguerre, J. P. Muh, and M. Chassaigne. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies. J. Pharm. Pharmacol. 42:473-476 (1990).
38. R. Dixon, J. Gourzis, D. McDermott, J. Fujitaki, P. Dewland, and H. Gruber. AICA-riboside: safety, tolerance and pharmacokinetics of a novel adenosine regulating agent. J. Clin. Pharmacol. 31:342-7 (1991).
39. D. Ratge, K. P. Kohse, U. Steegmüller, and H. Wisser. Distribution of free and conjugated catecholamines between plasma, platelets and erythrocytes; different effects of intravenous and oral catecholamine administrations. J. Pharmacol. Exp. Ther. 257:232-238 (1991).
40. K. Schmiegelow and I. Bruunshuus. 6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukaemia, and its relation to leukopenia. Cancer Chemother. Pharmacol. 26:288-292 (1990).
41. E. Rapaport and J. Fontaine. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc. Natl. Acad. Sci. USA 86:1662-6 (1989).
42. M. T. Fanelli-Kuczmarski, C. L. Johnson, L. Elias, and M. F. Najjar. Folate status of Mexican American, Cuban, and Puerto Rican women. Am. J. Clin. Nutr. 52:368-372 (1990).
43. A. Hercbergs, F. Brok-Simoni, F. Holtzman, J. Bar-am, J. T. Leith, and H. J. Brenner. Erythrocyte glutathione and tumour response to chemotherapy. Lancet 339:1074-1076 (1992).
44. S. Mangione, D. D. Patel, B. R. Levin, and S. B. Fiel. Erythrocytic glutathione in cystic fibrosis. A possible marker of pulmonary dysfunction. Chest 105:1470-73 (1994).
45. J. S. Lilleyman and L. Lennard. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia. Lancet 343:1188-90 (1994).
46. A. Melander, G. Brante, Ö. Johansson, T. Lindberg, and E. Wåhlin-Boll. Influence of food on the absorption of phenytoin in man. Eur. J. Clin. Pharmacol. 15:269-274 (1979).
47. M. C. Fernández, S. Erill, M. I. Lucena, E. Pita, and N. Pérez-Alférez. Serum protein binding of tolbutamide in patients treated with antiepileptic drugs. Clin. Pharmacokinet. 10:451-455 (1985).
48. T. J. B. Maling, R. W. L. Siebers, C. D. Burgess, C. Taylor, and G. Purdie. Individual variability of amiodarone distribution in plasma and erythrocytes: implications for therapeutic monitoring. Therap. Drug Monit. 11:121-126 (1989).
49. M. S. Highley, P. G. Harper, P. Slee, and E. A. De Bruijn. Preferential location of circulating activated cyclophosphamide within the erythrocyte. Int. J. Cancer In press.
50. O. Driessen, M. S. Highley, P. G. Harper, R. A. A. Maes, and E. A. De Bruijn. Description of an instrument for separation of red cells from plasma, and measurement of red cell volume. Clin. Biochem. 27:195-196 (1994).